IRISeg

K242461

Intuitive Surgical Inc. · cleared 2024-12-10 · product code QIH · Radiology

Premarket evidence — what FDA accepted

Device typesamd
source quote (p.4)
IRISeg is intended for use as a software application that receives DICOM compliant contrast-enhanced CT images, provides manual and machine learning-enabled tools for image analysis and segmentation, and creates an output file that can be used to render a 3D model for preoperative surgical planning and intraoperative display.
Algorithmneural network based ML algorithm
source quote (p.6)
The auto-segmentation algorithm is a neural network based ML algorithm.
Adaptive (vs locked)No
source quote (p.10)
No imaging study used to verify performance was used for training; independence of training and testing data were enforced at the level of the scanning institution, namely, studies sourced from a specific institution were used for either training or testing but could not be used for both.
PCCPFDA source did not state this
Cybersecurity addressedYes
source quote (p.10)
The cybersecurity verification and validation testing were conducted, and cybersecurity was evaluated per FDA's Guidance "Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions" (September, 2023). Specifically, addressing the following cybersecurity testing areas: security requirement testing, threat mitigation testing, vulnerability testing, and penetration testing. The cybersecurity verification and validation test results demonstrate the adequacy of the implemented cybersecurity controls.

Validation studies (1)

Retrospective clinical

n=81 scans

endpoints: Sørensen-Dice coefficient (DSC); Mean Distance to Agreement (MDA)

standards: ISO 14971, AAMI CR34971, IEC 62304 Edition 1.1 2015-06 Consolidated Version

Reported performance (3 observations)

diceas written: “Artery DSCstated without valueCI [0.87, 0.90]
source quote (p.10)
Artery DSC [0.87, 0.90]
diceas written: “Parenchyma DSCstated without valueCI [0.95, 0.97]
source quote (p.10)
Parenchyma DSC [0.95, 0.97]
diceas written: “Vein DSCstated without valueCI [0.87, 0.89]
source quote (p.10)
Vein DSC [0.87, 0.89]

Each value carries its own analysis unit and task — never compare or pool across devices. Source: 510(k) summary PDF.

Predicate network

Postmarket — what happened after clearance

0
recalls in product code, 24mo
3
MAUDE reports in code, 12mo
vs code's own 3-yr baseline
1
drift signals on this device
  • re_clearance

    The FDA AI/ML device list shows a newer 510(k) K251763 (decision 2025-12-16) from Intuitive Surgical, Inc. for a matching device line ("IRISeg") — a new clearance for the same line is a change event.

    first seen 2026-07-08 · k_number:K251763

Recall and MAUDE counts are product-code-level (reports aren't reliably attributable to one device). Signals are descriptive observables with sources — never a judgment that the device is unsafe or drifting. Snapshot 2026-07-08.

Reimbursement — how devices like this got paid

Not yet tracked — no payment pathway indexed for this clearance (the reimbursement corpus is a growing seed set).

RIGOR™ Precedent · public FDA/CMS data · descriptive decision-support, not regulatory or reimbursement advice. Share this page: radar.healthai.com/precedent/device/K242461